Usefulness of Belimumab in Adult Patients With Systemic Lupus Erythematosus Evaluated Using Single Indexes: A Meta-Analysis and Systematic Review

Background: Belimumab is the first antibody drug approved for systemic lupus erythematosus (SLE), and is a fully human monoclonal antibody that inhibits soluble B lymphocyte stimulator protein. In clinical trials, a composite index was used to assess efficacy of belimumab. However, clinical guidelin...

Full description

Bibliographic Details
Main Authors: Chisato Yoshijima, BSPharm, Yosuke Suzuki, PhD, Ayako Oda, BSPharm, Ryota Tanaka, PhD, Hiroyuki Ono, BSPharm, Hiroki Itoh, PhD, Keiko Ohno, PhD
Format: Article
Language:English
Published: Elsevier 2024-01-01
Series:Current Therapeutic Research
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0011393X24000080